1Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int, 2001,43:211-217.
2Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr,1996,128:146-149.
3Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics, 2000,105:E78.
4Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child, 2002,86:286-290.
5Fukunishi M, Kikkawa M, Hamana K,et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr, 2000,137:172-176.
6Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J, 1998,17:1144-1148.
7Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med, 1991,324:1633-1639.
8Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the seventh international Kawasaki disease symposium December 4-7, 2001, Hakone, Japan. Pediatr Res, 2003,53:153-157.
9Fong NC, Hui YW, Li CK, et al. Evaluation of the efficacy of treatment of Kawasaki disease before Day 5 of illness. Pediatr Cardiol, 2004,25:31-34.
10Saulsbury FT. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr, 2002,41:597-601.
